AVRO Annual Cash & Cash Equivalents
$98.02 M
+$5.46 M+5.90%
31 December 2023
Summary:
As of January 21, 2025, AVRO annual cash & cash equivalents is $98.02 million, with the most recent change of +$5.46 million (+5.90%) on December 31, 2023. During the last 3 years, it has fallen by -$161.66 million (-62.25%).AVRO Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AVRO Quarterly Cash And Cash Equivalents
$90.48 M
-$7.54 M-7.69%
31 March 2024
Summary:
As of January 21, 2025, AVRO quarterly cash and cash equivalents is $90.48 million, with the most recent change of -$7.54 million (-7.69%) on March 31, 2024. Over the past year, it has dropped by -$7.54 million (-7.69%).AVRO Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AVRO Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +5.9% | -7.7% |
| 3 y3 years | -62.3% | -22.0% |
| 5 y5 years | -22.4% | -22.0% |
AVRO Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -62.3% | -65.2% |
AVROBIO Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $90.48 M(-7.7%) |
| Dec 2023 | $98.02 M(+5.9%) | $98.02 M(-7.4%) |
| Sept 2023 | - | $105.84 M(-15.1%) |
| June 2023 | - | $124.69 M(+72.4%) |
| Mar 2023 | - | $72.33 M(-21.9%) |
| Dec 2022 | $92.56 M(-51.2%) | $92.56 M(-20.2%) |
| Sept 2022 | - | $115.97 M(-12.4%) |
| June 2022 | - | $132.41 M(-18.1%) |
| Mar 2022 | - | $161.66 M(-14.7%) |
| Dec 2021 | $189.57 M(-27.0%) | $189.57 M(-5.9%) |
| Sept 2021 | - | $201.37 M(-11.1%) |
| June 2021 | - | $226.44 M(-2.8%) |
| Mar 2021 | - | $233.03 M(-10.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $259.68 M(+38.8%) | $259.68 M(+18.3%) |
| Sept 2020 | - | $219.55 M(-10.2%) |
| June 2020 | - | $244.38 M(-5.2%) |
| Mar 2020 | - | $257.69 M(+37.8%) |
| Dec 2019 | $187.04 M(+48.1%) | $187.04 M(-9.4%) |
| Sept 2019 | - | $206.36 M(+128.4%) |
| June 2019 | - | $90.35 M(-16.7%) |
| Mar 2019 | - | $108.48 M(-14.1%) |
| Dec 2018 | $126.30 M(+2018.1%) | $126.30 M(-8.9%) |
| Sept 2018 | - | $138.58 M(-10.6%) |
| June 2018 | - | $155.01 M(+167.6%) |
| Mar 2018 | - | $57.93 M(+871.5%) |
| Dec 2017 | $5.96 M(+11.3%) | $5.96 M |
| Dec 2016 | $5.36 M | - |
FAQ
- What is AVROBIO annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for AVROBIO?
- What is AVROBIO annual cash & cash equivalents year-on-year change?
- What is AVROBIO quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for AVROBIO?
- What is AVROBIO quarterly cash and cash equivalents year-on-year change?
What is AVROBIO annual cash & cash equivalents?
The current annual cash & cash equivalents of AVRO is $98.02 M
What is the all time high annual cash & cash equivalents for AVROBIO?
AVROBIO all-time high annual cash & cash equivalents is $259.68 M
What is AVROBIO annual cash & cash equivalents year-on-year change?
Over the past year, AVRO annual cash & cash equivalents has changed by +$5.46 M (+5.90%)
What is AVROBIO quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of AVRO is $90.48 M
What is the all time high quarterly cash and cash equivalents for AVROBIO?
AVROBIO all-time high quarterly cash and cash equivalents is $259.68 M
What is AVROBIO quarterly cash and cash equivalents year-on-year change?
Over the past year, AVRO quarterly cash and cash equivalents has changed by -$7.54 M (-7.69%)